长链非编码RNA在乳腺癌中的研究进展
Research Progress of Long Noncoding RNA in Breast Cancer
DOI: 10.12677/WJCR.2022.122007, PDF,    科研立项经费支持
作者: 郑 欣, 刘 杰, 宋鹏霞, 姚水洪*, 罗 烨：衢州职业技术学院医学院生殖健康研究所，浙江 衢州
关键词: 乳腺癌；诊断；长链非编码RNA；竞争性内源RNA；耐药；分子靶标；Breast Cancer； Diagnosis； Long Noncoding RNA (lncRNA)； Competing Endogenous RNA (ceRNA)； Drug Resistance； Molecular Target
摘要: 乳腺癌是异质性的恶性肿瘤，发病率位居全球女性恶性肿瘤之首，传统的治疗手段如手术切除和放化疗的作用较为有限，而分子靶向治疗作为乳腺癌的新型治疗手段，具有效率高、特异性强和副作用小等优点。长链非编码RNA (long noncoding RNA, lncRNA)是一类长度大于200 nt且无蛋白编码功能的转录本，其参与细胞的多个生物学进程，进而在多种生理病理活动中起到关键调控的作用。随着高通量测序技术的发展，现已发现多种lncRNA在乳腺癌中异常表达，其与乳腺癌的发生、发展、转移以及耐药均密切相关，有望作为乳腺癌诊断、预后和治疗的分子靶标。
Abstract: As a heterogeneous malignant tumor, female breast cancer has become the most commonly diagnosed cancer worldwide. Conventional treatments such as surgical resection, radiotherapy and chemotherapy are not that useful. Molecular targeted therapy is a new way for breast cancer treatment, with high efficiency, high specificity and less side effects. LncRNA (long noncoding RNA) is a noncoding transcript with lengths over 200 nt. LncRNA modulates various biological functions and participates in a variety of physiological and pathological processes. With the development of transcriptome high-throughput sequencing, it has been found that abnormally expressed LncRNA is associated with occurrence, development, metastasis and drug resistancein breast cancer. lncRNA is expected to act as a molecular target for diagnosis, prognosis and treatment of breast cancer.
文章引用：郑欣, 刘杰, 宋鹏霞, 姚水洪, 罗烨. 长链非编码RNA在乳腺癌中的研究进展[J]. 世界肿瘤研究, 2022, 12(2): 52-60. https://doi.org/10.12677/WJCR.2022.122007

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
[Google Scholar] [CrossRef] [PubMed]
[2] Cao, W., Chen, H.D., Yu, Y.W., Li, N. and Chen, W.-Q. (2021) Changing Profiles of Cancer Burden Worldwide and in China: A Secondary Analysis of the Global Cancer Statistics 2020. Chinese Medical Journal, 134, 783-791.
[Google Scholar] [CrossRef] 
[3] Perou, C.M., Sorlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., et al. (2000) Molecular Portraits of Human Breast Tumours. Nature, 406, 747-752.
[Google Scholar] [CrossRef] [PubMed]
[4] Rakha, E.A., El-Sayed, M.E., Green, A.R., Lee, A.H.S., Robertson, J.F. and Ellis, I.O. (2007) Prognostic Markers in Triple-Negative Breast Cancer. Cancer, 109, 25-32.
[Google Scholar] [CrossRef] [PubMed]
[5] Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., et al. (2012) The GENCODE v7 Catalog of Human Long Noncoding RNAs: Analysis of Their Gene Structure, Evolution, and Expression. Genome Research, 22, 1775-1789.
[Google Scholar] [CrossRef] [PubMed]
[6] Wilusz, J.E., Sunwoo, H. and Spector, D.L. (2009) Long Noncoding RNAs: Functional Surprises from the RNA World. Genes & Development, 23, 1494-1504.
[Google Scholar] [CrossRef] [PubMed]
[7] Brannan, C.I., Dees, E.C., Ingram, R.S. and Tilghman, S.M. (1990) The Product of the H19 Gene May Function as an RNA. Molecular and Cellular Biology, 10, 28-36.
[Google Scholar] [CrossRef] [PubMed]
[8] The FANTOM Consortium and the RIKEN Genome Exploration Research Group Phase I & II Team (2002) Analysis of the Mouse Transcriptome Based on Functional Annotation of 60,770 Full-Length CDNAs. Nature, 420, 563-573.
[Google Scholar] [CrossRef] [PubMed]
[9] Blythe, A.J., Fox, A.H. and Bond, C.S. (2016) The Ins and Outs of LncRNA Structure: How, Why and What Comes Next? Biochimica et Biophysica Acta (BBA)—Gene Regulatory Mechanisms, 1859, 46-58.
[Google Scholar] [CrossRef] [PubMed]
[10] Liu, J., Peng, W.X., Mo, Y.Y. and Luo, D. (2017) MALAT1-Mediated Tumorigenesis. Frontiers in Bioscience, 22, 66-80.
[Google Scholar] [CrossRef] [PubMed]
[11] Koirala, P., Huang, J., Ho, T.T., Wu, F., Ding, X. and Mo, Y.Y. (2017) LncRNA AK023948 Is a Positive Regulator of AKT. Nature Communications, 8, Article No. 14422.
[Google Scholar] [CrossRef] [PubMed]
[12] Gupta, R.A., Shah, N., Wang, K.C., Kim, J., Horlings, H.M., Wong, D.J., et al. (2010) Long Non-Coding RNA HOTAIR Reprograms Chromatin State to Promote Cancer Metastasis. Nature, 464, 1071-1076.
[Google Scholar] [CrossRef] [PubMed]
[13] Godinho, M.F., Sieuwerts, A.M., Look, M.P., Meijer, D., Foekens, J.A., Dorssers, L.C.J., et al. (2010) Relevance of BCAR4 in Tamoxifen Resistance and Tumour Aggressiveness of Human Breast Cancer. British Journal of Cancer, 103, 1284-1291.
[Google Scholar] [CrossRef] [PubMed]
[14] Xing, Z., Lin, A., Li, C., Liang, K., Wang, S., Liu, Y., et al. (2014) LncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine Signals. Cell, 159, 1110-1125.
[Google Scholar] [CrossRef] [PubMed]
[15] Zheng, X., Han, H., Liu, G.P., Ma, Y.X., Pan, R.L., Sang, L.J., et al. (2017) LncRNA Wires up Hippo and Hedgehog Signaling to Reprogramme Glucose Metabolism. The EMBO Journal, 36, 3325-3335.
[Google Scholar] [CrossRef] [PubMed]
[16] Zheng, A., Song, X., Zhang, L., Zhao, L., Mao, X., Wei, M., et al. (2019) Long Non-Coding RNA LUCAT1/miR- 5582-3p/TCF7L2 Axis Regulates Breast Cancer Stemness via Wnt/Beta-Catenin Pathway. Journal of Experimental & Clinical Cancer Research, 38, Article No. 305.
[Google Scholar] [CrossRef] [PubMed]
[17] Mou, E. and Wang, H. (2019) LncRNA LUCAT1 Facilitates Tumorigenesis and Metastasis of Triple-Negative Breast Cancer through Modulating MiR-5702. Bioscience Reports, 39, BSR20190489.
[Google Scholar] [CrossRef] 
[18] Shi, Y., Li, J., Liu, Y., Ding, J., Fan, Y., Tian, Y., et al. (2015) The Long Noncoding RNA SPRY4-IT1 Increases the Proliferation of Human Breast Cancer Cells by Upregulating ZNF703 Expression. Molecular Cancer, 14, Article No. 51.
[Google Scholar] [CrossRef] [PubMed]
[19] Song, X., Zhang, X., Wang, X., Chen, L., Jiang, L., Zheng, A., et al. (2020) LncRNA SPRY4-IT1 Regulates Breast Cancer Cell Stemness through Competitively Binding MiR-6882-3p with TCF7L2. Journal of Cellular and Molecular Medicine, 24, 772-784.
[Google Scholar] [CrossRef] [PubMed]
[20] Lu, G., Li, Y., Ma, Y., Lu, J., Chen, Y., Jiang, Q., et al. (2018) Long Noncoding RNA LINC00511 Contributes to Breast Cancer Tumourigenesis and Stemness by Inducing the MiR-185-3p/E2F1/Nanog Axis. Journal of Experimental & Clinical Cancer Research, 37, Article No. 289.
[Google Scholar] [CrossRef] [PubMed]
[21] Shi, G., Cheng, Y., Zhang, Y., Guo, R., Li, S. and Hong, X. (2021) Long Non-Coding RNA LINC00511/miR-150/ MMP13 Axis Promotes Breast Cancer Proliferation, Migration and Invasion. Biochimica et Biophysica Acta (BBA)— Molecular Basis of Disease, 1867, Article ID: 165957.
[Google Scholar] [CrossRef] [PubMed]
[22] Liu, L., Zhu, Y., Liu, A.M., Feng, Y. and Chen, Y. (2019) Long Noncoding RNA LINC00511 Involves in Breast Cancer Recurrence and Radio Resistance by Regulating STXBP4 Expression via MiR-185. European Review for Medical and Pharmacological Sciences, 23, 7457-7468.
[Google Scholar] [CrossRef] [PubMed]
[23] Zhang, H., Zhao, B., Wang, X., Zhang, F. and Yu, W. (2019) LINC00511 Knockdown Enhances Paclitaxel Cytotoxicity in Breast Cancer Via Regulating MiR-29c/CDK6 Axis. Life Sciences, 228, 135-144.
[Google Scholar] [CrossRef] [PubMed]
[24] Liu, Y., Du, Y., Hu, X., Zhao, L. and Xia, W. (2018) Up-Regulation of CeRNA TINCR by SP1 Contributes to Tumorigenesis in Breast Cancer. BMC Cancer, 18, Article No. 367.
[Google Scholar] [CrossRef] [PubMed]
[25] Guo, F., Zhu, X., Zhao, Q. and Huang, Q. (2020) MiR5893p Sponged by the LncRNA TINCR Inhibits the Proliferation, Migration and Invasion and Promotes the Apoptosis of Breast Cancer Cells by Suppressing the Akt Pathway via IGF1R. International Journal of Molecular Medicine, 46, 989-1002.
[Google Scholar] [CrossRef] [PubMed]
[26] Wang, Q., Liu, J., You, Z., Yin, Y., Liu, L., Kang, Y., et al. (2021) LncRNA TINCR Favors Tumorigenesis via STAT3-TINCR-EGFR-Feedback Loop by Recruiting DNMT1 and Acting as a Competing Endogenous RNA in Human Breast Cancer. Cell Death & Disease, 12, Article No. 83.
[Google Scholar] [CrossRef] [PubMed]
[27] Dong, H., Hu, J., Zou, K., Ye, M., Chen, Y., Wu, C., et al. (2019) Activation of LncRNA TINCR by H3K27 Acetylation Promotes Trastuzumab Resistance and Epithelial-Mesenchymal Transition by Targeting MicroRNA-125b in Breast Cancer. Molecular Cancer, 18, Article No. 3.
[Google Scholar] [CrossRef] [PubMed]
[28] Xing, Z., Park, P.K., Lin, C. and Yang, L. (2015) LncRNA BCAR4 Wires up Signaling Transduction in Breast Cancer. RNA Biology, 12, 681-689.
[Google Scholar] [CrossRef] [PubMed]
[29] Zou, R., Chen, X., Jin, X., Li, S., Ou, R., Xue, J., et al. (2018) Up-Regulated BCAR4 Contributes to Proliferation and Migration of Cervical Cancer Cells. Surgical Oncology, 27, 306-313.
[Google Scholar] [CrossRef] [PubMed]
[30] Ouyang, S., Zheng, X., Zhou, X., Chen, Z., Yang, X. and Xie, M. (2017) LncRNA BCAR4 Promotes Colon Cancer Progression via Activating Wnt/Beta-Catenin Signaling. Oncotarget, 8, 92815-92826.
[Google Scholar] [CrossRef] [PubMed]
[31] Wang, L., Chunyan, Q., Zhou, Y., He, Q., Ma, Y., Ga, Y., et al. (2017) BCAR4 Increase Cisplatin Resistance and Predicted Poor Survival in Gastric Cancer Patients. European Review for Medical and Pharmacological Sciences, 21, 4064-4070.
[32] Gong, J., Zhang, H., He, L., Wang, L. and Wang, J. (2017) Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer. The Tohoku Journal of Experimental Medicine, 241, 29-34.
[Google Scholar] [CrossRef] [PubMed]
[33] Cai, Z., Wu, Y., Li, Y., Ren, J. and Wang, L. (2018) BCAR4 Activates GLI2 Signaling in Prostate Cancer to Contribute to Castration Resistance. Aging, 10, 3702-3712.
[Google Scholar] [CrossRef] [PubMed]
[34] Meijer, D., Van Agthoven, T., Bosma, P.T., Nooter, K. and Dorssers, L.C. (2006) Functional Screen for Genes Responsible for Tamoxifen Resistance in Human Breast Cancer Cells. Molecular Cancer Research, 4, 379-386.
[Google Scholar] [CrossRef] 
[35] Godinho, M.F., Wulfkuhle, J.D., Look, M.P., Sieuwerts, A.M., Sleijfer, S., Foekens, J.A., et al. (2012) BCAR4 Induces Antioestrogen Resistance But Sensitises Breast Cancer to Lapatinib. British Journal of Cancer, 107, 947-955.
[Google Scholar] [CrossRef] [PubMed]
[36] Sun, Y., Jin, S.D., Zhu, Q., Han, L., Feng, J., Lu, X.Y., et al. (2017) Long Non-Coding RNA LUCAT1 Is Associated with Poor Prognosis in Human Non-Small Lung Cancer and Regulates Cell Proliferation Via Epigenetically Repressing P21 and P57 Expression. Oncotarget, 8, 28297-28311.
[Google Scholar] [CrossRef] [PubMed]
[37] Khaitan, D., Dinger, M.E., Mazar, J., Crawford, J., Smith, M.A., Mattick, J.S., et al. (2011) The Melanoma-Upregulated Long Noncoding RNA SPRY4-IT1 Modulates Apoptosis and Invasion. Cancer Research, 71, 3852-3862.
[Google Scholar] [CrossRef] 
[38] Wu, H., Wang, Y., Chen, T., Li, Y., Wang, H., Zhang, L., et al. (2018) The N-Terminal Polypeptide Derived from VMIP-II Exerts Its Anti-Tumor Activity in Human Breast Cancer by Regulating LncRNA SPRY4-IT1. Bioscience Reports, 38, BSR20180411.
[Google Scholar] [CrossRef] 
[39] Xiang, Y., Chen, Y., Shi, Y., Wu, X., Hao, R., Li, Q., et al. (2019) Upregulation of the Long Non-Coding RNA SPRY4-IT1 Predicts Poor Prognosis in Breast Cancer. International Journal of Clinical and Experimental Pathology, 12, 1003-1008.
[40] Zheng, A., Zhang, L., Song, X. and Jin, F. (2020) Clinical Significance of SPRY4-IT1 in Efficacy and Survival Prediction in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy. Histology and Histopathology, 35, 361-370.
[Google Scholar] [CrossRef] [PubMed]
[41] Xu, S., Kong, D., Chen, Q., Ping, Y. and Pang, D. (2017) Oncogenic Long Noncoding RNA Landscape in Breast Cancer. Molecular Cancer, 16, Article No, 129.
[Google Scholar] [CrossRef] [PubMed]
[42] Yuan, Y., Li, E., Zhao, J., Wu, B., Na, Z., Cheng, W., et al. (2021) Highly Penetrating Nanobubble Polymer Enhances LINC00511-siRNA Delivery for Improving the Chemosensitivity of Triple-Negative Breast Cancer. Anti-Cancer Drugs, 32, 178-188.
[Google Scholar] [CrossRef] 
[43] Kretz, M. (2013) TINCR, Staufen1, and Cellular Differentiation. RNA Biology, 10, 1597-1601.
[Google Scholar] [CrossRef] [PubMed]
[44] Tian, F., Xu, J., Xue, F., Guan, E. and Xu, X. (2017) TINCR Expression Is Associated with Unfavorable Prognosis in Patients with Hepatocellular Carcinoma. Bioscience Reports, 37, BSR20170301.
[Google Scholar] [CrossRef] 
[45] Hou, A., Zhang, Y., Zheng, Y., Fan, Y., Liu, H. and Zhou, X. (2019) LncRNA Terminal Differentiation-Induced NcRNA (TINCR) Sponges MiR-302 to Upregulate Cyclin D1 in Cervical Squamous Cell Carcinoma (CSCC). Human Cell, 32, 515-521.
[Google Scholar] [CrossRef] [PubMed]
[46] Wang, X., Li, S., Xiao, H. and Deng, X. (2020) Serum LncRNA TINCR Serve as a Novel Biomarker for Predicting the Prognosis in Triple-Negative Breast Cancer. Technology in Cancer Research & Treatment, 19, 1-8.
[Google Scholar] [CrossRef] [PubMed]
[47] Liu, M., Xing, L.Q. and Liu, Y.J. (2017) A Three-Long Noncoding RNA Signature as a Diagnostic Biomarker for Differentiating Between Triple-Negative and Non-Triple-Negative Breast Cancers. Medicine, 96, Article No. e6222.
[Google Scholar] [CrossRef] 
[48] Zhang, K., Luo, Z., Zhang, Y., Zhang, L., Wu, L., Liu, L., et al. (2016) Circulating LncRNA H19 in Plasma as a Novel Biomarker for Breast Cancer. Cancer Biomarkers, 17, 187-194.
[Google Scholar] [CrossRef] 
[49] Zhang, Y., Zhang, K., Luo, Z., Liu, L., Wu, L. and Liu, J. (2016) Circulating Long Non-Coding HOX Transcript Antisense Intergenic Ribonucleic Acid in Plasma as a Potential Biomarker for Diagnosis of Breast Cancer. Thoracic Cancer, 7, 627-632.
[Google Scholar] [CrossRef] [PubMed]
[50] Fan, C.N., Ma, L. and Liu, N. (2019) Comprehensive Analysis of Novel Three-Long Noncoding RNA Signatures as a Diagnostic and Prognostic Biomarkers of Human Triple-Negative Breast Cancer. Journal of Cellular Biochemistry, 120, 3185-3196.
[Google Scholar] [CrossRef] [PubMed]
[51] Zhang, S., Ma, F., Xie, X. and Shen, Y. (2020) Prognostic Value of Long Non-Coding RNAs in Triple Negative Breast Cancer: A PRISMA-Compliant Meta-Analysis. Medicine, 99, Article No. e21861.
[Google Scholar] [CrossRef] 
[52] Bermejo, J.L., Huang, G., Manoochehri, M., Mesa, K.G., Schick, M., Silos, R.G., et al. (2019) Long Intergenic Noncoding RNA 299 Methylation in Peripheral Blood Is a Biomarker for Triple-Negative Breast Cancer. Epigenomics, 11, 81-93.
[Google Scholar] [CrossRef] [PubMed]

为你推荐